and veterinary, face the delicate challenge of diagnosis everyday but the tools available to them are far from perfect. Medical practitioners often have to trade off performance with convenience.
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes an accurate,
rapid and affordable molecular diagnostic platform at the Point-Of-Care: the VitaPCR.
Conscious of the necessity to simplify processes and accelerate diagnostics turnaround times at lower costs while ensuring the best accuracy, we provide solutions for diagnosis in the areas of Human Health.
The diagnostic companies have a moral responsibility and duty to the doctors and patients to provide better tools, and we envision that effective rapid POC Molecular Diagnostics will redefine healthcare for human clinical management.